CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 31 enrolled
Drug / intervention
Alvimopan +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02218190
NCT02218190N/ACompleted
CompareCT.gov

A Randomized Trial of Alvimopan for the Reduction of Ileus After Long Posterior Spinal Fusion

Washington University School of Medicine·interventional·Posted Aug 18, 2014·Updated May 17, 2019

In Brief

A clinical study evaluating Alvimopan and Placebo for Ileus and Spinal Fusion. Completed, enrolled 31 participants across 1 site.

Detailed Summary

The purpose of the study is to determine with Alvimopan reduces the incidence of post operative ileus in patients who undergo posterior spinal fusion.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsIleus, Spinal Fusion
CountriesUnited States
CollaboratorsOrthopedic Research and Education Foundation, Barnes-Jewish Hospital

Timeline

N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedAug 18, 2014
Enrollment StartAug 1, 2014
Primary CompletionJan 1, 2016
Study CompletionJan 1, 2019
TodayJul 2, 2026
Enrollment to primary: 1.4 yearsPosted 11.9 years ago

Interventions

Alvimopandrug

Placebodrug